Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms

Three hundred healthcare workers with mild symptoms for Covid-19 will be followed during three months. Each two weeks, serological tests will be performed. Re-infection will be monitored by saliva-swabs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Serology Virus Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sciensano

Brussels, 1050, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

HCW previous tested for Covid-19 with mild symptoms in Jessa Ziekenhuis, Belgium

Exclusion criteria

Treatment and study plan

Primary outcomes

Percentage of serological positive healthcare workers

Time frame: three months
Percentage of HCW with positive Saliva-sabs

Time frame: three months

Sponsors and collaborators

Lead sponsor

Sciensano

Other Gov

Collaborators

Jessa Hospital

Registry information

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Apr 22, 2020
Registry last updated: Sep 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed